Metastasis and stem cell pathways

Cancer and Metastasis Reviews

Volumn 26, Issue 2, 2007, Pages 261-271

  Barnhart, Bryan C ^a,b   Simon, M Celeste ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypoxia; Metastasis; Stem cell; Tumor

Indexed keywords

ABC TRANSPORTER; CHEMOKINE RECEPTOR CXCR4; DNA BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; METALLOPROTEINASE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN LYSINE 6 OXIDASE; UVOMORULIN;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; HUMAN; HYPOXIA; INFORMATION PROCESSING; METASTASIS; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SOMATIC CELL; TUMOR GROWTH; VASCULARIZATION;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM METASTASIS; STEM CELLS;

EID: 34547118111     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9053-3     Document Type: Review

References (90)

1. Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249-257.
2. Pouyssegur, J., Dayan, F., & Mazure, N. M. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature, 441, 437-443.
3. Brown, J. M., & Wilson, W. R. (2004). Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer, 4, 437-447.
4. Hockel, M., & Vaupel, P. (2001). Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute, 93, 266-276.
5. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
6. Rodesch, F., Simon, P., Donner, C., & Jauniaux, E. (1992). Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstetrics & Gynecology, 80, 283-285.
7. Lee, Y. M., Jeong, C. H., Koo, S. Y., Son, M. J., Song, H. S., Bae, S. K. et al., (2001). Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Developmental Dynamics, 220, 175-186.
8. Morriss, G. M., & New, D. A. (1979). Effect of oxygen concentration on morphogenesis of cranial neural folds and neural crest in cultured rat embryos. Journal of Embryology and Experimental Morphology, 54, 17-35.
9. 2 homeostasis by hypoxia-inducible factor 1. Annual Review of Cell and Developmental Biology, 15, 551-578.
10. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature, 386, 403-407.
11. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., et al. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes & Development, 12, 149-162.
12. Ryan, H. E., Lo, J., & Johnson, R. S. (1998). HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO Journal, 17, 3005-3015.
13. Pardal, R., Clarke, M. F., & Morrison, S. J. (2003). Applying the principles of stem-cell biology to cancer. Nature Reviews Cancer, 3, 895-902.
14. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645-648.
15. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3, 730-737.
16. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63, 5821-5828.
17. Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell, 11, 69-82.
18. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 3983-3988.
19. O'Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110.
20. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature, 445, 111-115.
21. Morrison, S. J., Shah, N. M., & Anderson, D. J. (1997). Regulatory mechanisms in stem cell biology. Cell, 88, 287-298.
22. Moore, K. A., & Lemischka, I. R. (2006). Stem cells and their niches. Science, 311, 1880-1885.
23. Joseph, N. M., & Morrison, S. J. (2005). Toward an understanding of the physiological function of Mammalian stem cells. Developments in Cell, 9, 173-183.
24. Li, L., & Xie, T. (2005). Stem cell niche: Structure and function. Annual Review of Cell and Developmental Biology, 21, 605-631.
25. Ohlstein, B., Kai, T., Decotto, E., & Spradling, A. (2004). The stem cell niche: Theme and variations. Current Opinion in Cell Biology, 16, 693-699.
26. Morrison, S. J., & Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441, 1068-1074.
27. Scadden, D. T. (2006). The stem-cell niche as an entity of action. Nature, 441, 1075-1079.
28. Li, L., & Neaves, W. B. (2006). Normal stem cells and cancer stem cells: The niche matters. Cancer Research, 66, 4553-4557.
29. Ezashi, T., Das, P., & Roberts, R. M. (2005). Low O2 tensions and the prevention of differentiation of hES cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 4783-4788.
30. Cipolleschi, M. G., Dello Sbarba, P., & Olivotto, M. (1993). The role of hypoxia in the maintenance of hematopoietic stem cells. Blood, 82, 2031-2037.
31. Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C., & Morrison, S. J. (2005). SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 121, 1109-1121.
32. Danet, G. H., Pan, Y., Luongo, J. L., Bonnet, D. A., & Simon, M. C. (2003). Expansion of human SCID-repopulating cells under hypoxic conditions. Journal of Clinical Investigation, 112, 126-135.
33. Adelman, D. M., Maltepe, E., & Simon, M. C. (1999). Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes & Development, 13, 2478-2483.
34. Adelman, D. M., Gertsenstein, M., Nagy, A., Simon, M. C., & Maltepe, E. (2000). Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes & Development, 14, 3191-3203.
35. Ramirez-Bergeron, D. L., Runge, A., Dahl, K. D., Fehling, H. J., Keller, G., & Simon, M. C. (2004). Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development, 131, 4623-4634.
36. Ramirez-Bergeron, D. L., Runge, A., Adelman, D. M., Gohil, M., & Simon, M. C. (2006). HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Developmental Cell, 11, 81-92.
37. Genbacev, O., Zhou, Y., Ludlow, J. W., & Fisher, S. J. (1997). Regulation of human placental development by oxygen tension. Science, 277, 1669-1672.
38. Morrison, S. J., Csete, M., Groves, A. K., Melega, W., Wold, B., & Anderson, D. J. (2000). Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. Journal of Neuroscience, 20, 7370-7376.
39. Studer, L., Csete, M., Lee, S. H., Kabbani, N., Walikonis, J., Wold, B., et al. (2000). Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. Journal of Neuroscience, 20, 7377-7383.
40. Polyak, K., & Hahn, W. C. (2006). Roots and stems: Stem cells in cancer. Nature Medicine, 12, 296-300.
41. Bjerkvig, R., Tysnes, B. B., Aboody, K. S., Najbauer, J., & Terzis, A. J. (2005). Opinion: The origin of the cancer stem cell: current controversies and new insights. Nature Reviews. Cancer, 5, 899-904.
42. Loh, Y. H., Wu, Q, Chew, J. L., Vega, V. B., Zhang, W., Chen, X., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics, 38, 431-440.
43. Wang, G. L., & Semenza, G. L. (1995). Purification and characterization of hypoxia-inducible factor 1. Journal of Biological Chemistry, 270, 1230-1237.
44. Liu, Y. V., Baek, J. H., Zhang, H., Diez, R., Cole, R. N., & Semenza, G. L. (2007). RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Molecular Cell, 25, 207-217.
45. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Molecular and Cellular Biology, 23, 9361-9374.
46. Wang, V., Davis, D. A., Haque, M., Huang, L. E., & Yarchoan, R. (2005). Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Research, 65, 3299-3306.
47. Raval, R. R., Lau, K. W., Tran, M. G., Sowter, H. M., Mandriota, S. J., Li, J. L., et al. (2005). Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Molecular and Cellular Biology, 25, 5675-5686.
48. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews. Cancer, 3, 721-732.
49. Covello, K. L., Kehler, J., Yu, H., Gordan, J. D., Arsham, A. M., Hu, C. J., et al. (2006). HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes & Development, 20, 557-570.
50. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell, 95, 379-391.
51. Niwa, H., Miyazaki, J., & Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics, 24, 372-376.
52. Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R., et al. (2005). Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell, 123, 917-929.
53. Gidekel, S., Pizov, G., Bergman, Y., & Pikarsky, E. (2003). Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell, 4, 361-370.
54. Covello, K. L., Simon, M. C., & Keith, B. (2005). Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth. Cancer Research, 65, 2277-2286.
55. Wilson, A., & Radtke, F. (2006). Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Letters, 580, 2860-2868.
56. Nofziger, D., Miyamoto, A., Lyons, K. M., & Weinmaster, G. (1999). Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development, 126, 1689-1702.
57. Weng, A. P., & Aster, J. C. (2004). Multiple niches for Notch in cancer: Context is everything. Current Opinion in Genetics & Development, 14, 48-54.
58. Gustafsson, M. V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., et al. (2005). Hypoxia requires notch signaling to maintain the undifferentiated cell state. Developments in Cell, 9, 617-628.
59. Kaidi, A., Williams, A. C., & Paraskeva, C. (2007). Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nature Cell Biology.
60. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., & Huang L.E. (2004). HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO Journal, 23, 1949-1956.
61. Gordan, J. D., Bertout, J. A., Hu, C. J., Diehl, J. A., & Simon, M. C. (2007). HIF-2alpha promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell (in press).
62. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
63. Koshiji, M., To, K. K., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., et al. (2005). HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Molecular Cell, 17, 793-803.
64. Nelson, D. A., Tan, T. T., Rabson, A. B., Anderson, D., Degenhardt, K., & White, E. (2004). Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes & Development, 18, 2095-2107.
65. Axelson, H., Fredlund, E., Ovenberger, M., Landberg, G., & Pahlman, S. (2005). Hypoxia-induced dedifferentiation of tumor cells-A mechanism behind heterogeneity and aggressiveness of solid tumors. Seminars in Cell & Developmental Biology, 16, 554-563.
66. Jogi, A., Ora, I., Nilsson, H., Lindeheim, A., Makino, Y., Poellinger, L., et al. (2002). Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proceedings of the National Academy of Sciences of the United States of America, 99, 7021-7026.
67. Helczynska, K., Kronblad, A., Jogi, A., Nilsson, E., Beckman, S., Landberg, G., et al. (2003). Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Research, 63, 1441-1444.
68. Lofstedt, T., Jogi, A., Sigvardsson, M., Gradin K, Poellinger, L., Pahlman, S., et al. (2004). Induction of ID2 expression by hypoxia-inducible factor-1: A role in dedifferentiation of hypoxic neuroblastoma cells. Journal of Biological Chemistry, 279, 39223-39231.
69. Liu, L., & Simon, M. C. (2004). Regulation of transcription and translation by hypoxia. Cancer Biology & Therapy, 3, 492-497.
70. Arsham, A. M., Howell, J. J., & Simon, M. C. (2003). A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. Journal of Biological Chemistry, 278, 29655-29660.
71. Connolly. E, Braunstein, S., Formenti, S., & Schneider, R. J. (2006). Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Molecular and Cellular Biology, 26, 3955-3965.
72. Fingar, D. C., Richardson, C. J., Tee, A. R., Cheatham, L., Tsou, C., & Blenis, J. (2004). mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Molecular and Cellular Biology, 24, 200-216.
73. Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002). Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes & Development, 16, 1472-1487.
74. Easton, J. B., & Houghton, P. J. (2006). mTOR and cancer therapy. Oncogene, 25, 6436-6446.
75. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., et al. (2006). TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell, 126, 955-968.
76. Li, F., Tiede, B., Massague, J., & Kang, Y. (2007). Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research, 17, 3-14.
77. Fidler, I. J., & Talmadge, J. E. (1986). Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Research, 46, 5167-5171.
78. Imai, T., Horiuchi, A., Wang, C., Oka, K., Ohira, S., & Nikaido, T., et al. (2003). Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. American Journal of Pathology, 163, 1437-1447.
79. Esteban, M. A., Tran, M. G., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., et al. (2006). Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Research, 66, 3567-3575.
80. Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., & Baek, J. H., et al. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Research, 66, 2725-2731.
81. Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhofer, N., Kong, C., Le, Q. T., et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440, 1222-1226.
82. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P.M. (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3, 347-361.
83. Boccaccio C., & Comoglio, P. M. (2006). Invasive growth: A MET-driven genetic programme for cancer and stem cells. Nature Reviews. Cancer, 6, 637-645.
84. Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003). Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature, 425, 307-311.
85. Chambers. A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563-572.
86. Dean, M., Fojo, T., & Bates S. (2005). Tumour stem cells and drug resistance. Nature Reviews. Cancer, 5, 275-284.
87. Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., et al. (2004). The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. Journal of Biological Chemistry, 279, 24218-24225.
88. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-760.
89. Al-Hajj, M., Becker, M. W., Wicha, M., Weissman, I., & Clarke, M. F. (2004). Therapeutic implications of cancer stem cells. Current Opinion in Genetics & Development, 14, 43-47.
90. Holmquist-Mengelbier, L., Fredlund, E., Lofstedt, T., Noguera, R., Navarro, S., Nilsson, H., et al. (2006). Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell, 10, 413-423.